Global CAR T-Cell-Based Drug Market 2023 by Company, Regions, Type and Application, Forecast to 2029

1 Market Overview

• 1.1 Product Overview and Scope of CAR T-Cell-Based Drug
• 1.2 Market Estimation Caveats and Base Year
• 1.3 Classification of CAR T-Cell-Based Drug by Type
  • 1.3.1 Overview: Global CAR T-Cell-Based Drug Market Size by Type: 2018 Versus 2022 Versus 2029
  • 1.3.2 Global CAR T-Cell-Based Drug Consumption Value Market Share by Type in 2022
  • 1.3.3 CD19-targeted
  • 1.3.4 BCMA-targeted
• 1.4 Global CAR T-Cell-Based Drug Market by Application
  • 1.4.1 Overview: Global CAR T-Cell-Based Drug Market Size by Application: 2018 Versus 2022 Versus 2029
  • 1.4.2 Lymphoma
  • 1.4.3 Multiple Myeloma
• 1.5 Global CAR T-Cell-Based Drug Market Size & Forecast
• 1.6 Global CAR T-Cell-Based Drug Market Size and Forecast by Region
  • 1.6.1 Global CAR T-Cell-Based Drug Market Size by Region: 2018 VS 2022 VS 2029
  • 1.6.2 Global CAR T-Cell-Based Drug Market Size by Region, (2018-2029)
  • 1.6.3 North America CAR T-Cell-Based Drug Market Size and Prospect (2018-2029)
  • 1.6.4 Europe CAR T-Cell-Based Drug Market Size and Prospect (2018-2029)
  • 1.6.5 Asia-Pacific CAR T-Cell-Based Drug Market Size and Prospect (2018-2029)
  • 1.6.6 South America CAR T-Cell-Based Drug Market Size and Prospect (2018-2029)
  • 1.6.7 Middle East and Africa CAR T-Cell-Based Drug Market Size and Prospect (2018-2029)

2 Company Profiles

• 2.1 Novartis
  • 2.1.1 Novartis Details
  • 2.1.2 Novartis Major Business
  • 2.1.3 Novartis CAR T-Cell-Based Drug Product and Solutions
  • 2.1.4 Novartis CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023)
  • 2.1.5 Novartis Recent Developments and Future Plans
• 2.2 Gilead Sciences
  • 2.2.1 Gilead Sciences Details
  • 2.2.2 Gilead Sciences Major Business
  • 2.2.3 Gilead Sciences CAR T-Cell-Based Drug Product and Solutions
  • 2.2.4 Gilead Sciences CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023)
  • 2.2.5 Gilead Sciences Recent Developments and Future Plans
• 2.3 Bristol-Myers Squibb
  • 2.3.1 Bristol-Myers Squibb Details
  • 2.3.2 Bristol-Myers Squibb Major Business
  • 2.3.3 Bristol-Myers Squibb CAR T-Cell-Based Drug Product and Solutions
  • 2.3.4 Bristol-Myers Squibb CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023)
  • 2.3.5 Bristol-Myers Squibb Recent Developments and Future Plans
• 2.4 J & J
  • 2.4.1 J & J Details
  • 2.4.2 J & J Major Business
  • 2.4.3 J & J CAR T-Cell-Based Drug Product and Solutions
  • 2.4.4 J & J CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023)
  • 2.4.5 J & J Recent Developments and Future Plans
• 2.5 JW Therapeutics
  • 2.5.1 JW Therapeutics Details
  • 2.5.2 JW Therapeutics Major Business
  • 2.5.3 JW Therapeutics CAR T-Cell-Based Drug Product and Solutions
  • 2.5.4 JW Therapeutics CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023)
  • 2.5.5 JW Therapeutics Recent Developments and Future Plans
• 2.6 FOSUNKite
  • 2.6.1 FOSUNKite Details
  • 2.6.2 FOSUNKite Major Business
  • 2.6.3 FOSUNKite CAR T-Cell-Based Drug Product and Solutions
  • 2.6.4 FOSUNKite CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023)
  • 2.6.5 FOSUNKite Recent Developments and Future Plans
• 2.7 CARsgen Therapeutics
  • 2.7.1 CARsgen Therapeutics Details
  • 2.7.2 CARsgen Therapeutics Major Business
  • 2.7.3 CARsgen Therapeutics CAR T-Cell-Based Drug Product and Solutions
  • 2.7.4 CARsgen Therapeutics CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023)
  • 2.7.5 CARsgen Therapeutics Recent Developments and Future Plans
• 2.8 Autolus Therapeutics
  • 2.8.1 Autolus Therapeutics Details
  • 2.8.2 Autolus Therapeutics Major Business
  • 2.8.3 Autolus Therapeutics CAR T-Cell-Based Drug Product and Solutions
  • 2.8.4 Autolus Therapeutics CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023)
  • 2.8.5 Autolus Therapeutics Recent Developments and Future Plans
• 2.9 Sorrento Therapeutics
  • 2.9.1 Sorrento Therapeutics Details
  • 2.9.2 Sorrento Therapeutics Major Business
  • 2.9.3 Sorrento Therapeutics CAR T-Cell-Based Drug Product and Solutions
  • 2.9.4 Sorrento Therapeutics CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023)
  • 2.9.5 Sorrento Therapeutics Recent Developments and Future Plans
• 2.10 Mustang Bio
  • 2.10.1 Mustang Bio Details
  • 2.10.2 Mustang Bio Major Business
  • 2.10.3 Mustang Bio CAR T-Cell-Based Drug Product and Solutions
  • 2.10.4 Mustang Bio CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023)
  • 2.10.5 Mustang Bio Recent Developments and Future Plans
• 2.11 Bluebird Bio
  • 2.11.1 Bluebird Bio Details
  • 2.11.2 Bluebird Bio Major Business
  • 2.11.3 Bluebird Bio CAR T-Cell-Based Drug Product and Solutions
  • 2.11.4 Bluebird Bio CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023)
  • 2.11.5 Bluebird Bio Recent Developments and Future Plans
• 2.12 Cellectis
  • 2.12.1 Cellectis Details
  • 2.12.2 Cellectis Major Business
  • 2.12.3 Cellectis CAR T-Cell-Based Drug Product and Solutions
  • 2.12.4 Cellectis CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023)
  • 2.12.5 Cellectis Recent Developments and Future Plans
• 2.13 Allogene Therapeutics
  • 2.13.1 Allogene Therapeutics Details
  • 2.13.2 Allogene Therapeutics Major Business
  • 2.13.3 Allogene Therapeutics CAR T-Cell-Based Drug Product and Solutions
  • 2.13.4 Allogene Therapeutics CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023)
  • 2.13.5 Allogene Therapeutics Recent Developments and Future Plans
• 2.14 Celyad
  • 2.14.1 Celyad Details
  • 2.14.2 Celyad Major Business
  • 2.14.3 Celyad CAR T-Cell-Based Drug Product and Solutions
  • 2.14.4 Celyad CAR T-Cell-Based Drug Revenue, Gross Margin and Market Share (2018-2023)
  • 2.14.5 Celyad Recent Developments and Future Plans

3 Market Competition, by Players

• 3.1 Global CAR T-Cell-Based Drug Revenue and Share by Players (2018-2023)
• 3.2 Market Share Analysis (2022)
  • 3.2.1 Market Share of CAR T-Cell-Based Drug by Company Revenue
  • 3.2.2 Top 3 CAR T-Cell-Based Drug Players Market Share in 2022
  • 3.2.3 Top 6 CAR T-Cell-Based Drug Players Market Share in 2022
• 3.3 CAR T-Cell-Based Drug Market: Overall Company Footprint Analysis
  • 3.3.1 CAR T-Cell-Based Drug Market: Region Footprint
  • 3.3.2 CAR T-Cell-Based Drug Market: Company Product Type Footprint
  • 3.3.3 CAR T-Cell-Based Drug Market: Company Product Application Footprint
• 3.4 New Market Entrants and Barriers to Market Entry
• 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

• 4.1 Global CAR T-Cell-Based Drug Consumption Value and Market Share by Type (2018-2023)
• 4.2 Global CAR T-Cell-Based Drug Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

• 5.1 Global CAR T-Cell-Based Drug Consumption Value Market Share by Application (2018-2023)
• 5.2 Global CAR T-Cell-Based Drug Market Forecast by Application (2024-2029)

6 North America

• 6.1 North America CAR T-Cell-Based Drug Consumption Value by Type (2018-2029)
• 6.2 North America CAR T-Cell-Based Drug Consumption Value by Application (2018-2029)
• 6.3 North America CAR T-Cell-Based Drug Market Size by Country
  • 6.3.1 North America CAR T-Cell-Based Drug Consumption Value by Country (2018-2029)
  • 6.3.2 United States CAR T-Cell-Based Drug Market Size and Forecast (2018-2029)
  • 6.3.3 Canada CAR T-Cell-Based Drug Market Size and Forecast (2018-2029)
  • 6.3.4 Mexico CAR T-Cell-Based Drug Market Size and Forecast (2018-2029)

7 Europe

• 7.1 Europe CAR T-Cell-Based Drug Consumption Value by Type (2018-2029)
• 7.2 Europe CAR T-Cell-Based Drug Consumption Value by Application (2018-2029)
• 7.3 Europe CAR T-Cell-Based Drug Market Size by Country
  • 7.3.1 Europe CAR T-Cell-Based Drug Consumption Value by Country (2018-2029)
  • 7.3.2 Germany CAR T-Cell-Based Drug Market Size and Forecast (2018-2029)
  • 7.3.3 France CAR T-Cell-Based Drug Market Size and Forecast (2018-2029)
  • 7.3.4 United Kingdom CAR T-Cell-Based Drug Market Size and Forecast (2018-2029)
  • 7.3.5 Russia CAR T-Cell-Based Drug Market Size and Forecast (2018-2029)
  • 7.3.6 Italy CAR T-Cell-Based Drug Market Size and Forecast (2018-2029)

8 Asia-Pacific

• 8.1 Asia-Pacific CAR T-Cell-Based Drug Consumption Value by Type (2018-2029)
• 8.2 Asia-Pacific CAR T-Cell-Based Drug Consumption Value by Application (2018-2029)
• 8.3 Asia-Pacific CAR T-Cell-Based Drug Market Size by Region
  • 8.3.1 Asia-Pacific CAR T-Cell-Based Drug Consumption Value by Region (2018-2029)
  • 8.3.2 China CAR T-Cell-Based Drug Market Size and Forecast (2018-2029)
  • 8.3.3 Japan CAR T-Cell-Based Drug Market Size and Forecast (2018-2029)
  • 8.3.4 South Korea CAR T-Cell-Based Drug Market Size and Forecast (2018-2029)
  • 8.3.5 India CAR T-Cell-Based Drug Market Size and Forecast (2018-2029)
  • 8.3.6 Southeast Asia CAR T-Cell-Based Drug Market Size and Forecast (2018-2029)
  • 8.3.7 Australia CAR T-Cell-Based Drug Market Size and Forecast (2018-2029)

9 South America

• 9.1 South America CAR T-Cell-Based Drug Consumption Value by Type (2018-2029)
• 9.2 South America CAR T-Cell-Based Drug Consumption Value by Application (2018-2029)
• 9.3 South America CAR T-Cell-Based Drug Market Size by Country
  • 9.3.1 South America CAR T-Cell-Based Drug Consumption Value by Country (2018-2029)
  • 9.3.2 Brazil CAR T-Cell-Based Drug Market Size and Forecast (2018-2029)
  • 9.3.3 Argentina CAR T-Cell-Based Drug Market Size and Forecast (2018-2029)

10 Middle East & Africa

• 10.1 Middle East & Africa CAR T-Cell-Based Drug Consumption Value by Type (2018-2029)
• 10.2 Middle East & Africa CAR T-Cell-Based Drug Consumption Value by Application (2018-2029)
• 10.3 Middle East & Africa CAR T-Cell-Based Drug Market Size by Country
  • 10.3.1 Middle East & Africa CAR T-Cell-Based Drug Consumption Value by Country (2018-2029)
  • 10.3.2 Turkey CAR T-Cell-Based Drug Market Size and Forecast (2018-2029)
  • 10.3.3 Saudi Arabia CAR T-Cell-Based Drug Market Size and Forecast (2018-2029)
  • 10.3.4 UAE CAR T-Cell-Based Drug Market Size and Forecast (2018-2029)

11 Market Dynamics

• 11.1 CAR T-Cell-Based Drug Market Drivers
• 11.2 CAR T-Cell-Based Drug Market Restraints
• 11.3 CAR T-Cell-Based Drug Trends Analysis
• 11.4 Porters Five Forces Analysis
  • 11.4.1 Threat of New Entrants
  • 11.4.2 Bargaining Power of Suppliers
  • 11.4.3 Bargaining Power of Buyers
  • 11.4.4 Threat of Substitutes
  • 11.4.5 Competitive Rivalry
• 11.5 Influence of COVID-19 and Russia-Ukraine War
  • 11.5.1 Influence of COVID-19
  • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

• 12.1 CAR T-Cell-Based Drug Industry Chain
• 12.2 CAR T-Cell-Based Drug Upstream Analysis
• 12.3 CAR T-Cell-Based Drug Midstream Analysis
• 12.4 CAR T-Cell-Based Drug Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology
• 14.2 Research Process and Data Source